# Ispecimen Inc. (ISPC)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $12M  
**Price:** $2.68 (-8.22%)

> iSpecimen Inc. operates a proprietary online marketplace platform that connects life science researchers worldwide with hospitals, laboratories, and other organizations supplying human biospecimens, subjects, samples, and associated data. The iSpecimen Marketplace streamlines procurement by offering a diverse range of human biospecimens, including biofluids such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissues like fresh, fixed, cryopreserved samples, as well as formalin-fixed paraffin-embedded blocks, slides, and curls; and hematopoietic stem and immune cells from bone marrow, cord blood, whole blood, or isolated components like peripheral blood mononuclear cells. This platform addresses challenges in accessing high-quality, diverse specimens for research in diagnostics and therapeutics. iSpecimen Inc. serves biopharmaceutical companies, in vitro diagnostic firms, and government/academic institutions, facilitating faster biomedical discovery through efficient, compliant global networking. Founded in 2009 and headquartered in Woburn, Massachusetts, it plays a key role in the healthcare sector's diagnostics and research industry.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $2M | $215,665 | -$9M | -$10M | $-2.28 |
| 2024 | $9M | $4M | -$13M | -$12M | $-17.58 |
| 2023 | $10M | $5M | -$11M | -$11M | $-24.55 |
| 2022 | $10M | $6M | -$10M | -$10M | $-1.16 |
| 2021 | $11M | $6M | -$6M | -$9M | $-2.09 |
| 2020 | $8M | $5M | -$2M | -$5M | $-4.97 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $10M | $6M | $3M | $7M | — |
| 2024 | $9M | $6M | $3M | $2M | — |
| 2023 | $16M | $6M | $10M | $2M | — |
| 2022 | $25M | $4M | $20M | $15M | — |
| 2021 | $36M | $6M | $30M | $28M | $3M |
| 2020 | $6M | $22M | -$27M | $695,909 | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$4M | $454 | -$4M |
| 2024 | -$8M | $31,546 | -$8M |
| 2023 | -$6M | $19,478 | -$6M |
| 2022 | -$6M | $215,504 | -$6M |
| 2021 | -$11M | $2,550 | -$11M |
| 2020 | -$288,380 | $426 | -$288,806 |

Source: [CompaniesByCap](https://companiesbycap.com/company/ISPC)